Drugs / HOE901-U300
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01658579 | Aug 2012 → May 2013 | type 1 diabetes mellitus | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HOE901-U300 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01658579 ↗ |
| Route | Subcutaneous | “HOE901-U300 (new insulin glargine 300 units per milliliter \[U/mL\]) subcutaneous (SC) injection” NCT01658579 ↗ |